ARTICLE | Company News
OctoPlus, Alcon deal
March 7, 2011 8:00 AM UTC
OctoPlus will develop a controlled-release formulation of an undisclosed biologic from Alcon's ESBATech AG research unit for ophthalmic use as part of an expanded 2009 deal. Financial terms were not ...